An interventional study of WIM Robotic Exoskeleton in Stroke and Healthy, sponsored by Shirley Ryan AbilityLab. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 89 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.
Sponsored by Shirley Ryan AbilityLab · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 64 studies in Stroke by Shirley Ryan AbilityLab — 12 open to participants now, 20 under way, none of them phase 3. Stroke · Shirley Ryan AbilityLab.
Among the 64 studies in Stroke by Shirley Ryan AbilityLab, this one is the 36th largest by planned enrollment of the 55 interventional ones that give a count, is one of 4 that started in 2025, is one of 49 with no phase, reaches primary completion later than 18 of the 19 other live ones, and was the 63rd registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →12 of the 64 studies in Stroke by Shirley Ryan AbilityLab are open now, in 1 country. Recruiting first, the newest first:
Shirley Ryan AbilityLab · Sites in United States
Ages 18+
Shirley Ryan AbilityLab · Sites in United States
Ages 40–70 · Healthy volunteers
Shirley Ryan AbilityLab · Sites in United States
Ages 18+ · Healthy volunteers
Shirley Ryan AbilityLab · Sites in United States
Ages 18+
Shirley Ryan AbilityLab · Sites in United States
Ages 18–89
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years to 89 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
64 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 2 · Phase 3 2
First in 2003; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 30 across the 55 interventional studies, 40 across the 9 observational. Of the 32 that completed or were terminated, 12 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
Shirley Ryan AbilityLab is the lead sponsor of 181 studies on the registry; 44 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 4 (40%) have results posted.
7 of the studies in Stroke by Shirley Ryan AbilityLab that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03300141Shirley Ryan AbilityLabLooking Glass: Bimanual Balanced Reaching With Visual Biofeedback | 2026-12 |
| NCT05076565Shirley Ryan AbilityLabWearable Airbag Technology to Mitigate Falls in Individuals With High Fall Risk | 2026-12-14 |
| NCT05471375Shirley Ryan AbilityLabC-STAR Movement Database | 2026-12-31 |
| NCT06234124Shirley Ryan AbilityLabCharacterization and Clinical Trial of a Variable Friction Shoe | 2027-01 |
| NCT06663501Shirley Ryan AbilityLabEffects of Vibration on Motor Function of Survivors of Chronic Stroke | 2027-03-01 |
Add all 7 to your calendar (.ics) → With an account.
Among the 64 studies in Stroke by Shirley Ryan AbilityLab, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is to develop, test, and optimize a soft hip wearable robot for individuals with stroke, Parkinson's, multiple sclerosis, or older adults with no neurologic deficits.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
For the Optimization Aim of the study, Participants may also be healthy individuals with no known impairments.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: WIM Robotic Exoskeleton
Wearable hip-powered exoskeleton
6-minute walk test
Primary outcome for Optimization aim of study.
Time frame: Baseline (Single-session)
Metabolic Cost
Primary outcome for Optimization aim of study. Data collected using Cosmed K5 Metabolic Unit
Time frame: Baseline (single session)
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2025 (actual). Primary completion is estimated for Jul 2028, 36 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 36 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.